RDEN News Alert Elizabeth Arden (RDEN) 16.59 02/14/2015 07:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Elizabeth Arden (RDEN) 16.59 $RDEN

Elizabeth Arden +4.1% after BMO Capital takes a shine
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 7:48AM CST

RDEN: 16.59 (+0.90)

Upgrade Alert for Elizabeth Arden (RDEN)
Comtex SmarTrend(R) - Fri Feb 13, 6:53AM CST
Elizabeth Arden (NASDAQ:RDEN) was upgraded from Market Perform to Outperform at BMO Capital today. The stock closed yesterday at $15.69 on volume of 256,000 shares, below average daily volume of 264,000. Elizabeth Arden, Inc. manufactures, distributes, and markets prestige fragrances and related skin treatment and cosmetic products for men and women. The Company's fragrance brands include Red Door, White Diamonds, Grey Flannel, Halston, Guerlain, and Nautica. Elizabeth Arden's skin care brands include Ceramides, Visible Difference, and Millenium.
RDEN: 16.59 (+0.90)

A Passing Cloud For Elizabeth Arden
Kevin Donovan - at Seeking Alpha - Wed Feb 11, 10:56AM CST

RDEN: 16.59 (+0.90)

Today In SA PRO: Thursday, February 5
SA PRO Top Ideas - at Seeking Alpha - Fri Feb 06, 4:00AM CST
Top Idea: Uranerz Energy by Itinerant: Long / Micro-Cap / Uranium Mining / GARP / Event-Special Situations / Takeover Target / Unjustified Sell-Off / Performance Award-Winning Author / 150% Upside Top Idea: Federal Agricultural Mortgage...
TSE: 17.27 (-0.18), RDEN: 16.59 (+0.90), AGM: 32.35 (+0.42), URZ: 1.18 (+0.01)

Elizabeth Arden's (RDEN) CEO Scott Beattie on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 7:34PM CST

RDEN: 16.59 (+0.90)

Elizabeth Arden reports 2Q loss
Automated Insights - Thu Feb 05, 4:18PM CST
MIRAMAR, Fla. (AP) _ Elizabeth Arden Inc. (RDEN) on Thursday reported a fiscal second-quarter loss of $56.1 million, after reporting a profit in the same period a year earlier.
RDEN: 16.59 (+0.90)

Elizabeth Arden misses by $0.31, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 3:39PM CST

RDEN: 16.59 (+0.90)

Elizabeth Arden, Inc. Announces Second Quarter Fiscal 2015 Results
Business Wire - Thu Feb 05, 3:01PM CST
Elizabeth Arden, Inc. (NASDAQ:RDEN), a global prestige beauty products company, today announced financial results for its second fiscal quarter ended December 31, 2014.
RDEN: 16.59 (+0.90)

Beautiful day for cosmetics stocks
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:36AM CST

REV: 33.05 (+0.13), IPAR: 27.54 (unch), RDEN: 16.59 (+0.90), COTY: 22.03 (unch), ULTA: 136.66 (+0.59), EL: 82.49 (+1.58)

Downtrend Call Working As Elizabeth Arden Stock Falls 15.9% (RDEN)
Comtex SmarTrend(R) - Thu Feb 05, 9:24AM CST
SmarTrend identified a Downtrend for Elizabeth Arden (NASDAQ:RDEN) on January 21st, 2015 at $17.54. In approximately 2 weeks, Elizabeth Arden has returned 15.88% as of today's recent price of $14.75.
RDEN: 16.59 (+0.90)

Wall Street Breakfast: Greece Slumps Following ECB Decision
Wall Street Breakfast - at Seeking Alpha - Thu Feb 05, 5:31AM CST

ACT: 285.37 (+3.71), BT: 67.71 (-1.86), NGHC: 18.23 (-0.24), SNE: 27.30 (+0.19), SLB: 88.38 (+2.42), ANTM: 141.05 (-0.95), SPY: 209.78 (+0.86), WFT: 12.17 (+0.55), INOD: 2.78 (-0.02), AAPL: 127.08 (+0.62), BHI: 64.31 (+1.93), FTR: 8.38 (+0.01), TSE: 17.27 (-0.18), RDEN: 16.59 (+0.90), HAL: 44.19 (+1.42), VOD: 35.85 (+0.14), DISH: 77.20 (-0.16), UA: 73.76 (-0.19), QQQ: 106.91 (+0.91), AZN: 69.96 (+0.20), GM: 37.62 (-0.40), VZ: 49.31 (-0.21), ORAN: 18.52 (+0.07)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:35PM CST

BEBE: 3.90 (+0.01), ACET: 20.00 (+0.27), ARCW: 6.62 (+0.23), CPST: 0.73 (+0.03), AIV: 38.55 (-0.50), DV: 36.69 (+0.04), EGAN: 3.78 (+0.08), CUTR: 11.94 (-0.21), MTD: 307.00 (-0.13), PXLW: 5.24 (-0.22), LNKD: 269.00 (+1.83), ADNC: 4.59 (-0.02), LGF: 32.17 (+0.08), AHL: 46.44 (-0.29), HME: 67.76 (-0.96), PDFS: 18.31 (+0.04), MCK: 224.89 (+0.12), KRG: 29.17 (+0.23), ATHN: 134.60 (+4.95), PCTY: 28.59 (+0.38), BRS: 61.71 (+3.65), ECOM: 9.69 (+0.63), FWM: 5.55 (+0.08), EXPE: 89.49 (-0.08), NTGR: 31.63 (+0.23), IMPV: 43.17 (+1.38), OLN: 27.31 (+0.13), MRIN: 7.04 (+0.04), BWLD: 187.27 (+0.30), ASYS: 9.87 (+0.30), DCT: 36.70 (+0.23), BCOV: 8.43 (+0.27), MXWL: 6.47 (+0.07), CME: 93.92 (-1.39), ATVI: 23.11 (+0.17), KIM: 26.83 (-0.25), P: 15.44 (+0.45), BMI: 60.09 (+0.56), OUTR: 68.39 (+2.22), CTRL: 13.39 (+0.10), GPRO: 45.27 (-0.02), ECHO: 26.72 (+0.35), RDEN: 16.59 (+0.90), NUAN: 14.26 (+0.20), ATR: 64.56 (+0.49), ACLS: 2.81 (+0.04), EGOV: 16.20 (+0.30), PDM: 18.79 (-0.15), FLDM: 37.93 (-0.47), BRKS: 12.08 (+0.04), FLT: 150.37 (+1.15), ASEI: 56.82 (+0.30), ENH: 64.63 (+0.15), CALD: 14.95 (+0.03), ONNN: 11.94 (+0.33), LF: 2.51 (+0.06)

Why Earnings Season Could Be Great for Elizabeth Arden (RDEN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:20AM CST
Elizabeth Arden is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
RDEN: 16.59 (+0.90)

Elizabeth Arden, Inc. Sets Date to Announce Second Quarter Fiscal 2015 Financial Results
Business Wire - Thu Jan 29, 8:00AM CST
Elizabeth Arden, Inc. (Nasdaq:RDEN), a global prestige beauty products company, invites investors to listen to a broadcast of the Company's conference call to discuss results for its second quarter fiscal 2015 ended December 31, 2014.
RDEN: 16.59 (+0.90)

Elizabeth Arden: High Debt, Low Returns
Doyle Publishing Ltd. - at Seeking Alpha - Sat Jan 24, 9:06AM CST

RDEN: 16.59 (+0.90)

Avon (AVP) Continues to Plunge: Should You Dump It Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 1:00PM CST
Share price of Avon Products Inc. (AVP) has tumbled nearly 54.4% year over year.
HELE: 77.94 (-0.34), AVP: 9.08 (+0.39), RDEN: 16.59 (+0.90), SAM: 303.26 (-0.97)

Coverage Update: Another Warning Bell Peals
Kevin Donovan - at Seeking Alpha - Fri Jan 16, 1:58PM CST

WFM: 56.15 (-0.15), UA: 73.76 (-0.19), COH: 39.85 (+0.64), AVP: 9.08 (+0.39), LB: 94.51 (-0.30), MAT: 27.61 (+0.17), RDEN: 16.59 (+0.90), TGT: 76.12 (-0.75), JCP: 8.05 (+0.14), M: 64.32 (-0.34), KORS: 73.27 (+1.72), GPS: 41.20 (-0.37), BKS: 24.51 (+0.07), EL: 82.49 (+1.58)

Helen of Troy (HELE) Beats on Q315 Earnings, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 1:50PM CST
Shares of consumer product company Helen of Troy Limited (HELE) rose 12.2% after the company reported better than expected results in third quarter fiscal 2015 on Jan 8, 2015.
HELE: 77.94 (-0.34), BWS: 29.28 (+0.12), DLTR: 76.82 (+0.97), RDEN: 16.59 (+0.90)

Bumpy start to the year for luxury retail stocks
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 10:04AM CST

PEJ: 36.97 (-0.02), RDEN: 16.59 (+0.90), TIF: 89.05 (+0.95), KORS: 73.27 (+1.72), RL: 135.20 (-0.60), FOSL: 98.44 (-0.30), COH: 39.85 (+0.64), VRA: 20.18 (+0.47), KATE: 33.89 (+0.05), EL: 82.49 (+1.58)

Personal Care Products
M2 - Fri Jan 09, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/2qmpb9/personal_care) has announced the addition of Plunkett Research Ltd's new report "Personal Care Products; Cosmetics and Makeup; Fragrances and Perfumes; and Hair Care Products Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Personal Care Products; Cosmetics and Makeup; Fragrances and Perfumes; and Hair Care Products Manufacturing Industry (U.S.) to reach $60.5 billion by 2021. - Personal Care Products; Cosmetics and Makeup; Fragrances and Perfumes; and Hair Care Products Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: - Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package - Complete benchmarking of the industry and its top companies - Deep industry and company financials This Report Features: - Historical data - Revenue forecasts, growth rates and CAGR - Operating ratios - Complete data for benchmarking a company to its industry and to specific leading companies - Benchmarking this industry to all U.S. industries - Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Key Topics Covered: I. Introduction II. Industry Description for this NAIC Code III. Industry Summary, Current Year IV. Employment and Establishment Count V. This Industry's Financial Data, U.S., With Revenue Projections to 2021 VI. Top Companies Profiled & Ranked VII. Appendix: Assumptions VIII. Data Description and Sources Companies Mentioned - Blyth, Inc. - CCA Industries, Inc. - DS Healthcare Group Inc - Elizabeth Arden, Inc. - Estee Lauder Companies Inc (The) - Inter Parfums Inc - Nu Skin Enterprises, Inc. - Physicians Formula Holdings, Inc. - Procter & Gamble Co - Revlon Inc For more information visit http://www.researchandmarkets.com/research/2q...sonal_care Source: Plunkett Research Ltd
REV: 33.05 (+0.13), BTH: 7.99 (-0.17), IPAR: 27.54 (unch), CAW: 3.47 (+0.03), RDEN: 16.59 (+0.90), NUS: 56.92 (-1.30), PG: 85.90 (-0.13), EL: 82.49 (+1.58), DSKX: 0.79 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arkestro Recognized as Leading Sourcing Tech Solution in 2024

Updated Category News Views 138

Arkestro Celebrated as a Leading Sourcing Technology Provider Arkestro's innovative Predictive Procurement Orchestration AI platform has been recognized among the top contenders in the industry. This recognition comes as part of Spend Matters' release of their Fall 2024 SolutionMap, which acknowledges the leading procurement technology vendors. Out of 93 companies...

Continue Reading
Nanoscope Therapeutics Welcomes Ademola Daramola as VP of Quality

Updated Category News Views 178

Nanoscope Therapeutics Expands Leadership Team Nanoscope Therapeutics Inc., a dedicated biotechnology firm, strives to restore vision for blind patients through pioneering gene therapies. The company has recently appointed Ademola Daramola, D.Sc., as the Vice President of Quality and Compliance. Introducing Dr. Ademola Daramola Dr. Daramola joins Nanoscope with an...

Continue Reading
Lumentum Holdings Readies for Earnings Report with Optimism

Updated Category News Views 220

Lumentum Holdings Prepares for Earnings Release Lumentum Holdings (NASDAQ: LITE) is set to announce its quarterly earnings soon. Investors are eager to see what insights will emerge from the report, as expectations build around the company's performance. Investor Expectations and Earnings Forecast Analysts predict that Lumentum Holdings will post an earnings per share...

Continue Reading
LightPath Technologies Launches Infrared Solutions for Defense

Updated Category News Views 130

LightPath Technologies Initiates Delivery of Infrared Assemblies FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025 LightPath Technologies, Inc. (NASDAQ: LPTH), renowned for its advanced optics and imaging systems targeted at both defense and commercial utilizations, has announced that it...

Continue Reading
The RealReal Boosts Revenue and Adjusted EBITDA in Q3 2024

Updated Category News Views 57

Strong Q3 2024 Performance for The RealReal The RealReal (NASDAQ: REAL), a leader in the online marketplace for authenticated, resale luxury goods, reported significant financial gains in the third quarter of 2024. The company achieved a revenue of $148 million, which represents an increase of $15 million or 11% compared to the previous year. Notably, they also saw...

Continue Reading